Developer docs
API playgroundTry for free, no card

Search company profiles

Valkit.ai

Full company profile

uuid00076bl

Namestring
Valkit.ai
Legal namestring
Valkit.ai LLC
Websiteurl
valkit.ai
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Valkit.ai is a cloud-native SaaS provider of digital validation software for the life sciences industry, serving pharmaceutical, biotechnology, and medical device organizations alongside CDMOs and greenfield facility projects. The company's flagship platform, SAFE GxP DVT, is a Gen 2 digital validation tool built on the S.A.F.E. framework (Safe, Agnostic, Fast, End-to-End) that combines human-in-the-loop AI, an LLM-agnostic architecture, rapid content authoring, and continuous lifecycle traceability from requirements through regulatory sign-off. Supporting modules include Valkit MSAT (GxP tech transfer for MSAT-led CDMO engagements), Valkit GREENFIELD (digital C&Q for new site start-ups), and operational modules for documents, traceability, real-time project dashboards, AI-augmented assurance, and enterprise security. A pre-validated R1125 'Odin' package is delivered with every release to compress customer qualification cycles.

The platform is monetized primarily through SaaS subscriptions on a project-license basis with multi-year contracts, featuring no named-seat fees, unlimited collaborators, and optional managed services delivered through certified channel partners across the US, UK, EU, India, and APAC. Distribution combines direct enterprise field sales with a partner network — most notably an August 2025 strategic partnership with Life Science Consulting (Conval Group) covering India operations and extending into Asia and Europe. Infrastructure spans 19 Amazon regions with 10-language support. Compliance posture is layered, including ISO 27001:2022, CSA STAR Level One and CSA STAR for AI Level One, EU/UK/Swiss Data Privacy Framework certifications, GDPR/CCPA alignment, and 21 CFR Part 11 / EU GMP Annex 11 readiness for electronic records and signatures.

Short descriptiontext

Valkit.ai provides a cloud-native, AI-augmented digital validation SaaS platform for pharmaceutical, biotechnology, and medical device companies, automating GxP-compliant lifecycle workflows from requirements through regulatory sign-off.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersIndianapolis, United States
HQ citystring
Indianapolis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
GxP validation software, digital validation platform, computer system validation, commissioning and qualification, pharmaceutical compliance software
Industry2 codes
PRIMARYHLAGAJAI
Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHDAEANAE
Enterprise AI Governance, Risk & Compliance Platforms (Model Risk, Audit, Policies)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
GxP Digital Validation Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1SaaS Platform Subscription (Project License)
TypeSubscription Recurring
Description

Cloud-native SaaS subscription model structured around project licenses. Each project license covers a full validation engagement — from kick-off to sign-off — with no per-seat fees, no overage charges, and predictable spend. No named seat fees; unlimited collaborators included at no additional cost.

valkit.ai
2Optional Managed Services
TypeManaged Services
Description

Recurring fee for fully managed delivery via approved Valkit delivery partners. Based on partner geography, capability level, and engagement utilization. Covers end-to-end C&Q engagement managed entirely within the Valkit platform.

valkit.ai
3One-Time Implementation Fee
TypeProfessional Services
Description

One-time implementation fee paid at project kick-off, covering onboarding, platform configuration, template cloning, user provisioning, and team training. No implementation fee mentioned in some contexts (frictionless cloud-based approach).

valkit.ai
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations, Others
Pricing details3 tiers
1Valkit MSAT - GxP tech transfer for MSAT-led CDMO engagements
ModelSubscriptionBilling cadenceMulti-year contract
Notes

One project license. Every feature included. No feature gates. No named seats — every stakeholder has access at no additional cost.

valkit.ai
2Valkit GREENFIELD - Digital C&Q for new site start-up
ModelSubscriptionBilling cadenceMulti-year contract
Notes

One price. One project. One engagement. Fixed project license fee covers full duration — scoped per engagement. No per-seat fees. No overage charges. Optional managed service fee via approved delivery partner.

valkit.ai
3Subscription
ModelSubscriptionBilling cadenceAnnual
Notes

Flexible pricing plans tailored to organization needs. Contact sales team at sales@valkit.ai for details.

valkit.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1SAFE GxP DVT
Description

S.A.F.E. framework: human-in-the-loop AI for GxP digital validation - a proprietary framework combining Safe, Agnostic, Fast, and End-to-End principles for regulated digital validation.

valkit.ai
+2 more records
Core offering1 text field

Valkit.ai sells a cloud-native Gen 2 SaaS digital validation platform — anchored by its flagship SAFE GxP DVT product built on the proprietary S.A.F.E. framework (Safe, Agnostic, Fast, End-to-End) — that automates the GxP validation lifecycle for pharmaceutical, biotech, and medical device organizations. The platform covers requirements authoring, risk assessment, paperless test execution (IQ/OQ/PQ), automated traceability matrices, deviation management, and 21 CFR Part 11 / EU Annex 11 e-signatures, augmented by an LLM-agnostic agentic AI layer with mandatory human-in-the-loop review.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 80% reduction in lifecycle validation costs through smart automations, packages cloning, master data management, and AI augmentation
+7 more records
Product overview1 text field

Valkit.ai is a comprehensive Gen 2 digital validation platform for the life sciences industry, combining a modular architecture of specialized modules with AI-powered automation. The core platform is anchored by SAFE GxP DVT, the company's flagship AI-powered digital validation tool built on the S.A.F.E. framework. Supporting modules include Valkit MSAT (for GxP tech transfer and MSAT-led CDMO engagements), Valkit GREENFIELD (for digital C&Q at new site start-ups), and core operational modules for Project Management & Cloning, Documents, Traceability, Real-Time Dashboards, AI-Augmented Assurance, and Security. All modules share the same platform infrastructure, with a pre-validated R1125 'Odin' platform delivering validation packages (VP, PRD, FRA, OQ, TMX, VSR) with every release. The platform integrates natively with Jira and Azure DevOps and supports custom LLM APIs.

Product and service3 records
1SAFE GxP DVT
CategoryCore Platform
Description

The flagship AI-powered digital validation product built on the S.A.F.E. framework. SAFE stands for Safe (human-in-the-loop AI where every AI output requires mandatory human review and e-signature before entering the record), Agnostic (open LLM architecture not locked to any single AI provider), Fast (rapid authoring from system descriptions, uploaded docs, or unstructured legacy sources), and End-to-End (single continuous lifecycle from requirements through risk assessment, test execution, and sign-off). It targets pharmaceutical, biotech, and medical device organizations running CQV, CSV, CSA, instrument validation, lab validation, and cleaning validation under GxP regulations.

2Valkit MSAT
CategoryProduct Module
Description

A GxP tech transfer platform purpose-built for MSAT-led CDMO engagements. It enables disciplined and repeatable tech transfer projects between pharmaceutical sponsors and CDMOs within one isolated project environment, providing clear ownership, full transparency, and fixed project licensing. Sold as a separate product on a multi-year project-license subscription basis with every feature included and no named seats.

3Valkit GREENFIELD
CategoryProduct Module
Description

A digital C&Q platform for new pharmaceutical, biotech, and medical device site start-ups. Provides paperless IQ/OQ/PQ protocol execution, AI-augmented authoring, and zero-GDP-error execution, designed to take a facility from ground-break to qualified status. Sold as a separate product on a multi-year project-license subscription basis with unlimited collaborators and an optional managed service fee via approved delivery partners.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Life Science Consulting Pvt Limited (Conval Group Company)
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-08-19
Description

Life Science Consulting Pvt Limited, a Conval Group Company and 25-year validation services leader, became Valkit.ai's country partner for India operations. This strategic partnership expands access to Valkit.ai's AI-powered digital validation platform across Asia and Europe. The partnership combines Valkit.ai's cloud-native platform (delivering 80% reduction in lifecycle validation costs and 50% faster execution) with Conval's extensive expertise serving over 200 pharmaceutical clients including Novartis, Pfizer, and Roche. The collaboration targets the global testing and commissioning market valued at $254 billion in 2024, projected to reach $366.9 billion by 2033.

expresspharma.in
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct competitor offering a digital validation platform (ValGenesis VLMS) for life sciences covering CQV, CSV, and process validation. Targets the same pharmaceutical, biotech, and medical device buyers with a comparable SaaS value proposition and is widely considered the category leader Valkit must displace.

TypeEmerging player
Description

Qualio provides a cloud QMS for life sciences startups and mid-market companies, including document control and validation support. It addresses a similar GxP compliance pain point as Valkit but with a broader QMS frame and a focus on smaller pre-IPO life sciences organizations.

TypeBroad incumbent
Description

LabWare is a leading LIMS/ELN vendor used by pharma, biotech, and contract labs. It is a broad incumbent in adjacent laboratory informatics and shares overlap with Valkit's lab validation use cases, though LabWare's center of gravity is the lab itself rather than the validation lifecycle.

TypeBroad incumbent
Description

MasterControl provides a broad life sciences QMS/eQMS platform that includes document control, training, and validation tooling. It is an incumbent at many of the same regulated customers Valkit targets but with a much wider product footprint rather than a validation-specialist focus.

TypeBroad incumbent
Description

Veeva is the dominant enterprise SaaS platform for life sciences across CRM, regulatory, quality, and clinical. Its Vault Quality and Validation offerings overlap with parts of Valkit's surface area and define the procurement-default incumbent for many large pharma accounts.

TypeEmerging player
Description

Dot Compliance offers a Salesforce-native eQMS/QMS platform for life sciences covering deviations, CAPA, audits, and change control. It overlaps with Valkit's compliance-adjacent use cases and targets similar mid-market and enterprise pharma/biotech buyers with a modern cloud-native posture.

TypeEmerging player
Description

Greenlight Guru is a QMS and quality management platform purpose-built for medical device companies, overlapping with Valkit's medical device validation segment. It is a relevant adjacent peer for the MD&D portion of Valkit's customer base.

TypeBroad incumbent
Description

TrackWise (now part of Honeywell) is an enterprise quality management platform widely deployed in life sciences for deviations, CAPA, change control, and validation workflows. It is a broad incumbent with overlapping validation-related capabilities serving many of the same large pharma customers.

TypeDirect peer
Description

Kneat Gx is a cloud-based computerized system validation (CSV) and commissioning/qualification platform used by top-tier pharma and medical device manufacturers. It competes head-to-head with Valkit across C&Q, CSV, and lab validation use cases.

TypeDirect peer
Description

AssurX delivers configurable quality management and compliance workflow software for regulated industries including life sciences. Its validation and document control capabilities compete with parts of Valkit's Trace and Documents modules for the same GxP customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Valkit.ai

GxP Digital Validation Softwarevalkit.ai

Valkit.ai provides a cloud-native, AI-augmented digital validation SaaS platform for pharmaceutical, biotechnology, and medical device companies, automating GxP-compliant lifecycle workflows from requirements through regulatory sign-off.

What Valkit.ai does

Valkit.ai is a cloud-native SaaS provider of digital validation software for the life sciences industry, serving pharmaceutical, biotechnology, and medical device organizations alongside CDMOs and greenfield facility projects. The company's flagship platform, SAFE GxP DVT, is a Gen 2 digital validation tool built on the S.A.F.E. framework (Safe, Agnostic, Fast, End-to-End) that combines human-in-the-loop AI, an LLM-agnostic architecture, rapid content authoring, and continuous lifecycle traceability from requirements through regulatory sign-off. Supporting modules include Valkit MSAT (GxP tech transfer for MSAT-led CDMO engagements), Valkit GREENFIELD (digital C&Q for new site start-ups), and operational modules for documents, traceability, real-time project dashboards, AI-augmented assurance, and enterprise security. A pre-validated R1125 'Odin' package is delivered with every release to compress customer qualification cycles.

The platform is monetized primarily through SaaS subscriptions on a project-license basis with multi-year contracts, featuring no named-seat fees, unlimited collaborators, and optional managed services delivered through certified channel partners across the US, UK, EU, India, and APAC. Distribution combines direct enterprise field sales with a partner network — most notably an August 2025 strategic partnership with Life Science Consulting (Conval Group) covering India operations and extending into Asia and Europe. Infrastructure spans 19 Amazon regions with 10-language support. Compliance posture is layered, including ISO 27001:2022, CSA STAR Level One and CSA STAR for AI Level One, EU/UK/Swiss Data Privacy Framework certifications, GDPR/CCPA alignment, and 21 CFR Part 11 / EU GMP Annex 11 readiness for electronic records and signatures.

Valkit.ai firmographics

Firmographics
Name
Valkit.ai
Legal name
Valkit.ai LLC
Website
https://valkit.ai
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
11–50 employees
Short description
Valkit.ai provides a cloud-native, AI-augmented digital validation SaaS platform for pharmaceutical, biotechnology, and medical device companies, automating GxP-compliant lifecycle workflows from requirements through regulatory sign-off.
Ownership category
akta.pro rank

Valkit.ai industry classification

Industry
Product category
GxP Digital Validation Software
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAI
Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHDAEANAE
Enterprise AI Governance, Risk & Compliance Platforms (Model Risk, Audit, Policies)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise

Keywords

  • GxP validation software
  • Digital validation platform
  • Computer system validation
  • Commissioning and qualification
  • Pharmaceutical compliance software

Where Valkit.ai is headquartered

Location

Headquarters

HQ city
Indianapolis
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Valkit.ai business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations, Others

Revenue model

  1. SaaS Platform Subscription (Project License): Cloud-native SaaS subscription model structured around project licenses. Each project license covers a full validation engagement — from kick-off to sign-off — with no per-seat fees, no overage charges, and predictable spend. No named seat fees; unlimited collaborators included at no additional cost.
  2. Optional Managed Services: Recurring fee for fully managed delivery via approved Valkit delivery partners. Based on partner geography, capability level, and engagement utilization. Covers end-to-end C&Q engagement managed entirely within the Valkit platform.
  3. One-Time Implementation Fee: One-time implementation fee paid at project kick-off, covering onboarding, platform configuration, template cloning, user provisioning, and team training. No implementation fee mentioned in some contexts (frictionless cloud-based approach).

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractValkit MSAT - GxP tech transfer for MSAT-led CDMO engagements
SubscriptionMulti-year contractValkit GREENFIELD - Digital C&Q for new site start-up
SubscriptionAnnualFlexible pricing plans tailored to organization needs. Contact sales team at sales@valkit.ai for details.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Valkit.ai product offering

Product offering

Core offering

Valkit.ai sells a cloud-native Gen 2 SaaS digital validation platform — anchored by its flagship SAFE GxP DVT product built on the proprietary S.A.F.E. framework (Safe, Agnostic, Fast, End-to-End) — that automates the GxP validation lifecycle for pharmaceutical, biotech, and medical device organizations. The platform covers requirements authoring, risk assessment, paperless test execution (IQ/OQ/PQ), automated traceability matrices, deviation management, and 21 CFR Part 11 / EU Annex 11 e-signatures, augmented by an LLM-agnostic agentic AI layer with mandatory human-in-the-loop review.

Product overview

Valkit.ai is a comprehensive Gen 2 digital validation platform for the life sciences industry, combining a modular architecture of specialized modules with AI-powered automation. The core platform is anchored by SAFE GxP DVT, the company's flagship AI-powered digital validation tool built on the S.A.F.E. framework. Supporting modules include Valkit MSAT (for GxP tech transfer and MSAT-led CDMO engagements), Valkit GREENFIELD (for digital C&Q at new site start-ups), and core operational modules for Project Management & Cloning, Documents, Traceability, Real-Time Dashboards, AI-Augmented Assurance, and Security. All modules share the same platform infrastructure, with a pre-validated R1125 'Odin' platform delivering validation packages (VP, PRD, FRA, OQ, TMX, VSR) with every release. The platform integrates natively with Jira and Azure DevOps and supports custom LLM APIs.

Differentiator

Problem solved

Functional benefit

Brands

  • SAFE GxP DVT: S.A.F.E. framework: human-in-the-loop AI for GxP digital validation - a proprietary framework combining Safe, Agnostic, Fast, and End-to-End principles for regulated digital validation.
  • Valkit MSAT
  • Valkit GREENFIELD

Products and services

  • SAFE GxP DVT The flagship AI-powered digital validation product built on the S.A.F.E. framework. SAFE stands for Safe (human-in-the-loop AI where every AI output requires mandatory human review and e-signature before entering the record), Agnostic (open LLM architecture not locked to any single AI provider), Fast (rapid authoring from system descriptions, uploaded docs, or unstructured legacy sources), and End-to-End (single continuous lifecycle from requirements through risk assessment, test execution, and sign-off). It targets pharmaceutical, biotech, and medical device organizations running CQV, CSV, CSA, instrument validation, lab validation, and cleaning validation under GxP regulations.
  • Valkit MSAT A GxP tech transfer platform purpose-built for MSAT-led CDMO engagements. It enables disciplined and repeatable tech transfer projects between pharmaceutical sponsors and CDMOs within one isolated project environment, providing clear ownership, full transparency, and fixed project licensing. Sold as a separate product on a multi-year project-license subscription basis with every feature included and no named seats.
  • Valkit GREENFIELD A digital C&Q platform for new pharmaceutical, biotech, and medical device site start-ups. Provides paperless IQ/OQ/PQ protocol execution, AI-augmented authoring, and zero-GDP-error execution, designed to take a facility from ground-break to qualified status. Sold as a separate product on a multi-year project-license subscription basis with unlimited collaborators and an optional managed service fee via approved delivery partners.

Quantifiable outcome

  • 80% reduction in lifecycle validation costs through smart automations, packages cloning, master data management, and AI augmentation
  • +7 more outcomes

Companies that use Valkit.ai

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles5 records

Valkit.ai technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability7 records

Feature8 records

Valkit.ai partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Life Science Consulting Pvt Limited (Conval Group Company)coreChannel Partner/ Reseller/ Distributor · 19 August 2025Life Science Consulting Pvt Limited, a Conval Group Company and 25-year validation services leader, became Valkit.ai's country partner for India operations. This strategic partnership expands access to Valkit.ai's AI-powered digital validation platform across Asia and Europe. The partnership combines Valkit.ai's cloud-native platform (delivering 80% reduction in lifecycle validation costs and 50% faster execution) with Conval's extensive expertise serving over 200 pharmaceutical clients including Novartis, Pfizer, and Roche. The collaboration targets the global testing and commissioning market valued at $254 billion in 2024, projected to reach $366.9 billion by 2033.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Valkit.ai competitors and assessment

Company assessment

Direct peers

  • ValGenesis: Direct competitor offering a digital validation platform (ValGenesis VLMS) for life sciences covering CQV, CSV, and process validation. Targets the same pharmaceutical, biotech, and medical device buyers with a comparable SaaS value proposition and is widely considered the category leader Valkit must displace.
  • Kneat Solutions: Kneat Gx is a cloud-based computerized system validation (CSV) and commissioning/qualification platform used by top-tier pharma and medical device manufacturers. It competes head-to-head with Valkit across C&Q, CSV, and lab validation use cases.
  • AssurX: AssurX delivers configurable quality management and compliance workflow software for regulated industries including life sciences. Its validation and document control capabilities compete with parts of Valkit's Trace and Documents modules for the same GxP customer base.

Emerging players

  • Qualio: Qualio provides a cloud QMS for life sciences startups and mid-market companies, including document control and validation support. It addresses a similar GxP compliance pain point as Valkit but with a broader QMS frame and a focus on smaller pre-IPO life sciences organizations.
  • Dot Compliance: Dot Compliance offers a Salesforce-native eQMS/QMS platform for life sciences covering deviations, CAPA, audits, and change control. It overlaps with Valkit's compliance-adjacent use cases and targets similar mid-market and enterprise pharma/biotech buyers with a modern cloud-native posture.
  • Greenlight Guru: Greenlight Guru is a QMS and quality management platform purpose-built for medical device companies, overlapping with Valkit's medical device validation segment. It is a relevant adjacent peer for the MD&D portion of Valkit's customer base.

Broad incumbents

  • LabWare: LabWare is a leading LIMS/ELN vendor used by pharma, biotech, and contract labs. It is a broad incumbent in adjacent laboratory informatics and shares overlap with Valkit's lab validation use cases, though LabWare's center of gravity is the lab itself rather than the validation lifecycle.
  • MasterControl: MasterControl provides a broad life sciences QMS/eQMS platform that includes document control, training, and validation tooling. It is an incumbent at many of the same regulated customers Valkit targets but with a much wider product footprint rather than a validation-specialist focus.
  • Veeva Systems: Veeva is the dominant enterprise SaaS platform for life sciences across CRM, regulatory, quality, and clinical. Its Vault Quality and Validation offerings overlap with parts of Valkit's surface area and define the procurement-default incumbent for many large pharma accounts.
  • Sparta Systems (Honeywell TrackWise): TrackWise (now part of Honeywell) is an enterprise quality management platform widely deployed in life sciences for deviations, CAPA, change control, and validation workflows. It is a broad incumbent with overlapping validation-related capabilities serving many of the same large pharma customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Customer concentration

Valkit.ai social profiles

Digital presence

Valkit.ai compliance and trust

Trust signal

Compliance9 records

Valkit.ai financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Valkit.ai leadership team

Management profile

Number of profiles

Profiles4 records

Valkit.ai funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Valkit.ai M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Valkit.ai

What does Valkit.ai do?

Valkit.ai sells a cloud-native Gen 2 SaaS digital validation platform — anchored by its flagship SAFE GxP DVT product built on the proprietary S.A.F.E. framework (Safe, Agnostic, Fast, End-to-End) — that automates the GxP validation lifecycle for pharmaceutical, biotech, and medical device organizations. The platform covers requirements authoring, risk assessment, paperless test execution (IQ/OQ/PQ), automated traceability matrices, deviation management, and 21 CFR Part 11 / EU Annex 11 e-signatures, augmented by an LLM-agnostic agentic AI layer with mandatory human-in-the-loop review.

Is Valkit.ai a public or private company?

Valkit.ai is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Valkit.ai founded?

Valkit.ai was founded in 2024. It employs 11 to 50 people.

Where is Valkit.ai based?

Valkit.ai is headquartered in Indianapolis, United States, in the North America region.

How does Valkit.ai make money?

Three revenue lines are on record. SaaS Platform Subscription (Project License) is the primary driver. The others are optional Managed Services and one-Time Implementation Fee.

Who are Valkit.ai's main competitors?

Direct peers on record are ValGenesis, Kneat Solutions and AssurX. Emerging players are Qualio, Dot Compliance and Greenlight Guru. Broad incumbents are LabWare, MasterControl, Veeva Systems and Sparta Systems (Honeywell TrackWise).

Does Valkit.ai have an API?

No public API is recorded for Valkit.ai.

What industry is Valkit.ai in?

Valkit.ai's product category is GxP Digital Validation Software. Its primary akta.pro industry code is HLAGAJAI, Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs), with a secondary code of HDAEANAE, Enterprise AI Governance, Risk & Compliance Platforms (Model Risk, Audit, Policies). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireValkit.ai Launches Valkit LIFT to Import and Upgrade Legacy Validation TemplatesValkit.ai launched Valkit LIFT, a tool that imports Word and Gen 1 DVT/VLMS templates and upgrades them in one action. The tool maps sections to Valkit features, applies upgrades like e-signatures and trace matrices, and reports changes line by line. It works across whole template libraries, merging duplicates and flagging gaps.EIN PresswireValkit.ai Launches Valkit LIFT to Import and Upgrade Legacy Validation TemplatesValkit.ai launched Valkit LIFT, a tool that imports Word and Gen 1 DVT/VLMS templates and upgrades them in one action. The tool maps sections to Valkit features, applies upgrades like e-signatures and trace matrices, and reports changes. It works across whole libraries, merging duplicates and flagging gaps.EIN PresswireLeading U.S. Diagnostics Laboratory Selects Valkit.ai to Modernize ValidationA leading U.S. diagnostics laboratory with over $700M in revenue selected Valkit.ai to replace document-heavy validation with a connected, risk-based digital assurance platform. The platform integrates requirements, risks, testing, evidence, and approvals with built-in traceability and AI assistance, keeping qualified personnel accountable.EIN PresswireLeading U.S. Diagnostics Laboratory Selects Valkit.ai to Modernize ValidationA leading U.S. diagnostics laboratory with over $700M in revenue selected Valkit.ai to replace document-heavy validation with a connected, risk-based digital approach. The platform integrates requirements, risks, testing, evidence, and approvals with built-in traceability and human-governed AI assistance.EIN PresswireValkit.ai Names Provalis Latam as Exclusive Regional Partner for Latin AmericaValkit.ai named Provalis Latam its exclusive regional partner for Latin America, combining its AI-native digital validation platform with Provalis Latam's 25+ years of GMP services. The partnership aims to help regional manufacturers move beyond paper-based validation, with Valkit.ai expecting further regional partnerships soon.EIN PresswireGlobal Lab Technology Leader Selects Valkit.ai, Replacing Legacy Validation ToolA global lab technology leader with $6.95B annual revenue has selected Valkit.ai to replace its legacy digital validation tool. Valkit.ai will serve as the company's digital validation platform of record, supporting full CSV lifecycle management. The company cites architecture as the deciding factor, noting two displacements of the same Gen 1 platform in recent weeks.EIN PresswireValkit.ai Launches Valkit Greenfield for New Site Commissioning & QualificationValkit.ai launched Valkit Greenfield, a digital commissioning and qualification platform for new site start-up, running on its pre-validated R1125 Odin platform. The project-based solution offers unlimited collaboration, AI-augmented authoring, and fixed project licensing with no per-seat fees. Customers can go live in 2–4 weeks via Express Implementation.EIN PresswireProject Farma Partners with Valkit.ai to Modernize Digital Validation with AIProject Farma announced its Gold Tier Certified Partner status with Valkit.ai, an AI-powered digital validation platform. The partnership aims to modernize validation in regulated environments, improving data integrity and traceability while maintaining cGMP compliance. Valkit.ai's platform streamlines GxP activities like CQV, CSV, and CSA through automation and AI.EIN Presswirevalkit.ai Appoints SaaS and Investment Technology Leader Brian Nejmeh to Advisory Boardvalkit.ai appointed Brian Nejmeh to its advisory board, citing his SaaS and investment technology expertise. Nejmeh's framework for evaluating AI's impact on enterprise value aligns with valkit.ai's AI-native GxP validation platform. The appointment comes as the company expands its customer base across pharmaceutical and life sciences organizations.EIN PresswireValkit.ai Launches Valkit MSAT for GxP Tech Transfer and CDMO ValidationValkit.ai announced the general availability of Valkit MSAT, a GxP-compliant platform for tech transfer and CDMO validation. It offers fixed-fee licensing, AI-assisted authoring, and CDMO isolation, with three Gold Tier partners certified. The platform runs on Valkit's Odin R1125 release and is compliant with 21 CFR Part 11 and EU GMP Annex 11.